Eusa Pharma
Showing 1 - 25 of 210
Large Granular Lymphocyte Leukemia Trial in Tampa (Siltuximab)
Recruiting
- Large Granular Lymphocyte Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Mar 30, 2022
Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)
Recruiting
- Leiomyosarcoma
- Dinutuximab Beta, Zoledronic acid, Interleukin-2
-
Bad Saarow, Germany
- +1 more
Jun 2, 2022
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Siltuximab
- Spartalizumab
-
Atlanta, Georgia
- +2 more
Feb 1, 2022
Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide
Recruiting
- Castleman Disease
- +8 more
-
Philadelphia, Pennsylvania
- +9 more
Dec 5, 2022
Neuroblastoma Trial in Worldwide (Data-collection)
Recruiting
- Neuroblastoma
- Data-collection
-
Wien,, Vienna, Austria
- +13 more
Oct 28, 2022
Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR
Completed
- Healthy
- Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Mar 2, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- asparaginase Erwinia chrysanthemi
-
Los Angeles, California
- +21 more
Jun 1, 2021
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg
Active, not recruiting
- Hypertension
- Coronary Artery Disease
- Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
- Norvasc 5 mg tablets of Pfizer Labs
-
Vadodara, Gujarat, IndiaAccutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023
Pregnancy Related, Nausea Trial in Moscow (Doxylamine + Pyridoxine)
Recruiting
- Pregnancy Related
- Nausea
- Doxylamine + Pyridoxine
-
Moscow, Russian FederationLlc "Certa Clinic"
Aug 9, 2022
Unresectable Angiosarcoma Trial in Tokyo (BNCT)
Recruiting
- Unresectable Angiosarcoma
- BNCT
-
Tokyo, JapanNational Cancer Center Hospital
Nov 21, 2022
Drug Use Trial in Jakarta (Glimepiride, Amaryl®)
Completed
- Drug Use
-
Jakarta, DKI Jakarta, IndonesiaPT Pharma Metric Labs
Jul 20, 2022
Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg
Recruiting
- Healthy
- Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Aug 4, 2022
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)
Not yet recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Type 1 Diabetes, Hypoglycemia Trial in Bern (Micro-glucagon, Mini-glucagon)
Not yet recruiting
- Type 1 Diabetes
- Hypoglycemia
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and
May 19, 2022
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023
Alveolar Ridge Trauma, Bone Resorption Trial in Padova (Bone grafting)
Recruiting
- Alveolar Ridge Trauma
- Bone Resorption
- Bone grafting
-
Padova, ItalyFranci Institute
Mar 29, 2022
Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)
Recruiting
- Dry Eye Disease
- 0.09% cyclosporine A ophthalmic solution
-
Waterloo, Ontario, CanadaUniversity of Waterloo
Jul 13, 2023
Type 2 Diabetes Trial in Zibo (14028 injection, dulaglutide injection)
Recruiting
- Type 2 Diabetes
- 14028 injection
- dulaglutide injection
-
Zibo, Shandong, ChinaPKUCare Luzhong Hospital
Jul 12, 2022
Infertility, Female Trial in Bani Suwayf (Sildenafil Citrate, Clomiphene Citrate 50mg)
Completed
- Infertility, Female
- Sildenafil Citrate
- Clomiphene Citrate 50mg
-
Banī Suwayf, EgyptBeni-suef university
Apr 26, 2023
COVID-19 Vaccination Trial in Hong Kong (BNT162b2, CoronaVac)
Active, not recruiting
- COVID-19 Vaccination
- BNT162b2
- CoronaVac
-
Hong Kong, Hong KongThe University of Hong Kong
Feb 8, 2022